Page results
-
Having proton beam therapy: information for teenagers aged 13-17 patient information
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Interventional Radiology team.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
File results
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0041 - International recruitment
-
FOI/2023/0054 - Local formulary used at the Trust
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0064 - Children's operations cancelled/ delayed for non-clinical reasons from 2018 to 2022
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments
-
FOI/2023/0111 - Migraine treatment